NCT01704118

Brief Summary

Objective of this prospective, randomized and controlled study is to compare the performances of recently-released size 1 I-gel and size 1 PLMA proven to be superior to classical LMA with prospective studies. In this study, primer endpoint was value of airway leak pressure and secondary insertion time, insertion success and conditions, initial airway quality, hemodynamic parameters, fiberoptic view and complications will be assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2012

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2012

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2012

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

October 4, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 11, 2012

Completed
Last Updated

October 11, 2012

Status Verified

October 1, 2012

Enrollment Period

8 months

First QC Date

October 4, 2012

Last Update Submit

October 9, 2012

Conditions

Keywords

I-gelProSeal laryngeal masksmall infantsneonates

Outcome Measures

Primary Outcomes (1)

  • Airway leak pressure

    Fresh gas flow will adjust to 3 L.min-1, and after closing the expiratory valve the airway pressure at which an audible leak in the mouth occurred will be recorded as the 'Pleak'.

    1 year (After anesthesia induction)

Secondary Outcomes (4)

  • Insertion time and conditions

    1year (During maintainance of anesthesia)

  • Initial airway quality

    During maintainance of anesthesia

  • Evaluation of fiberoptic view

    1 year (During maintainance of anesthesia)

  • Complications

    1year(During maintainance of anesthesia)

Study Arms (2)

I-gel

EXPERIMENTAL

I-gel (Intersurgical Ltd, Wokingham, Berkshire, UK) is a disposable supraglottic airway device with a non-inflatable cuff in which part of that is fixed on glottis is made of thermoplastic elastomer, unlike other laryngeal masks

Device: I-gel

ProSeal Laryngeal mask

ACTIVE COMPARATOR

ProSeal laryngeal mask (PLMA) (LMA North America, Inc., San Diego, USA) is a modified type of LMA (larger and deeper bowl and enlarged and softer cuff) with gastric drainage tube.

Device: ProSeal Laryngeal mask

Interventions

I-gelDEVICE

Supraglottic airway device

I-gel

Supraglottic airway device

Also known as: PLMA
ProSeal Laryngeal mask

Eligibility Criteria

AgeUp to 6 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infants and neonates, that to be used supraglottic airway and that plan to be taken elective surgery

You may not qualify if:

  • Infants having a history of pulmonary disease and expect to have aspiration (gastroesophageal reflux, gastrointestinal stenosis or stricture) and a difficult airway

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inonu University Turgut Ozal Medical Center

Malatya, 44315, Turkey (Türkiye)

Location

Related Publications (1)

  • Kayhan GE, Begec Z, Sanli M, Gedik E, Durmus M. Performance of size 1 I-gel compared with size 1 ProSeal laryngeal mask in anesthetized infants and neonates. ScientificWorldJournal. 2015;2015:426186. doi: 10.1155/2015/426186. Epub 2015 Feb 22.

Study Officials

  • Gulay Erdogan Kayhan

    Assistant Professor, MD

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Prof,MD

Study Record Dates

First Submitted

October 4, 2012

First Posted

October 11, 2012

Study Start

January 1, 2012

Primary Completion

September 1, 2012

Study Completion

October 1, 2012

Last Updated

October 11, 2012

Record last verified: 2012-10

Locations